4

Changes in Ownership

C4 Therapeutics, Inc. Filed 2020-10-06 Acc 0000899243-20-027697

Director bought 5,030 shares at $19.00 ($95,570)

Director acquired 4,203,757 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
COHEN MARC A Director	2020-10-06	Conversion	+237,149			370,024	I
COHEN MARC A Director	2020-10-06	Conversion	+1,482,183			1,852,207	I
COHEN MARC A Director	2020-10-06	Conversion	+2,484,425			2,484,425	I
COHEN MARC A Director	2020-10-06	Purchase	+5,030	$19.00	$95,570	5,030	D
Derivatives
COHEN MARC A Director	2020-10-06	Conversion · Series Seed Preferred Stock	−2,000,000			0	I
COHEN MARC A Director	2020-10-06	Conversion · Series A Preferred Stock	−12,500,000			0	I
COHEN MARC A Director	2020-10-06	Conversion · Series B Preferred Stock	−20,952,403			0	I
Open-market purchases · 5,030 sh · avg $19.00 · $95,570